Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORE: Prednisolone vs Dexamethasone Bioequivalence
NCT04733144Phase 1Unknown
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2021
- Primary completion
- May 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of prednisolone and dexamethasone in inflammation (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Suppression of the hypothalamic-pituitary-adrenal axis - low dose at 1 week and Suppression of the hypothalamic-pituitary-adrenal axis - high dose at 1 week. Status: unknown.
02
Drugs
prednisolonedexamethasone
03
Conditions
inflammation
Beyond the preview
Go deeper on NCT04733144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04733144.